A meta-analysis of randomized placebo-controlled treatment trials for depression and anxiety in Parkinson’s disease

Background: Psychopharmacotherapy currently constitutes the first-line treatment for depression and anxiety in Parkinson’s disease (PD) however the efficacy of antidepressant treatments in PD is unclear. Several alternative treatments have been suggested as potentially more viable alternatives inclu...

Full description

Bibliographic Details
Main Authors: Troeung, L., Egan, Sarah, Gasson, Natalie
Format: Journal Article
Published: Public Library of Science 2013
Online Access:http://hdl.handle.net/20.500.11937/2764

Similar Items